B. Borelli, G. Zucchelli, D. Rossini, C. Cremolini, C. Antoniotti, R. Moretto, F. Marmorino, C. Colombo, F. Vannini, L. Delliponti, M. Spione, E. Ongaro, G. Masi, I. Brunetti, E. Pfanner, L. Salvatore, A. Falcone
{"title":"三氟尿苷/替吡拉西治疗转移性结直肠癌的临床回顾性研究","authors":"B. Borelli, G. Zucchelli, D. Rossini, C. Cremolini, C. Antoniotti, R. Moretto, F. Marmorino, C. Colombo, F. Vannini, L. Delliponti, M. Spione, E. Ongaro, G. Masi, I. Brunetti, E. Pfanner, L. Salvatore, A. Falcone","doi":"10.2217/CRC-2017-0023","DOIUrl":null,"url":null,"abstract":"Beatrice Borelli1, Gemma Zucchelli1, Daniele Rossini1, Chiara Cremolini1, Carlotta Antoniotti1, Roberto Moretto1, Federica Marmorino1, Camilla Colombo1, Francesca Vannini1, Laura Delliponti1, Mario Spione2, Elena Ongaro3, Gianluca Masi1, Isa Maura Brunetti1, Elisabetta Pfanner1, Lisa Salvatore1 & Alfredo Falcone*,1 1Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research & New Technologies in Medicine, University of Pisa, Pisa, Italy 2Medical Affairs, Servier Italia SpA, Roma, Italy 3Department of Oncology, Azienda Sanitaria Universitaria Integrata S. Maria della Misericordia, Udine, Italy * Author for correspondence: alfredo.falcone@med.unipi.it","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":"7 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/CRC-2017-0023","citationCount":"4","resultStr":"{\"title\":\"A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice\",\"authors\":\"B. Borelli, G. Zucchelli, D. Rossini, C. Cremolini, C. Antoniotti, R. Moretto, F. Marmorino, C. Colombo, F. Vannini, L. Delliponti, M. Spione, E. Ongaro, G. Masi, I. Brunetti, E. Pfanner, L. Salvatore, A. Falcone\",\"doi\":\"10.2217/CRC-2017-0023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Beatrice Borelli1, Gemma Zucchelli1, Daniele Rossini1, Chiara Cremolini1, Carlotta Antoniotti1, Roberto Moretto1, Federica Marmorino1, Camilla Colombo1, Francesca Vannini1, Laura Delliponti1, Mario Spione2, Elena Ongaro3, Gianluca Masi1, Isa Maura Brunetti1, Elisabetta Pfanner1, Lisa Salvatore1 & Alfredo Falcone*,1 1Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research & New Technologies in Medicine, University of Pisa, Pisa, Italy 2Medical Affairs, Servier Italia SpA, Roma, Italy 3Department of Oncology, Azienda Sanitaria Universitaria Integrata S. Maria della Misericordia, Udine, Italy * Author for correspondence: alfredo.falcone@med.unipi.it\",\"PeriodicalId\":43638,\"journal\":{\"name\":\"Colorectal Cancer\",\"volume\":\"7 1\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2018-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/CRC-2017-0023\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Colorectal Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/CRC-2017-0023\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/CRC-2017-0023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice
Beatrice Borelli1, Gemma Zucchelli1, Daniele Rossini1, Chiara Cremolini1, Carlotta Antoniotti1, Roberto Moretto1, Federica Marmorino1, Camilla Colombo1, Francesca Vannini1, Laura Delliponti1, Mario Spione2, Elena Ongaro3, Gianluca Masi1, Isa Maura Brunetti1, Elisabetta Pfanner1, Lisa Salvatore1 & Alfredo Falcone*,1 1Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research & New Technologies in Medicine, University of Pisa, Pisa, Italy 2Medical Affairs, Servier Italia SpA, Roma, Italy 3Department of Oncology, Azienda Sanitaria Universitaria Integrata S. Maria della Misericordia, Udine, Italy * Author for correspondence: alfredo.falcone@med.unipi.it
期刊介绍：
Colorectal cancer is a major cause of morbidity and mortality, particularly in the developed world. Risk factors for colorectal cancer are on the rise in many countries; populations are aging, and obesity and diabetes are increasing. National screening programs are helping to detect cancer while it is still curable; however, colorectal cancer remains the third leading cause of cancer deaths in the USA and options are still limited for those with more advanced disease. Consequently, colorectal cancer is a major research priority for government, pharmaceutical companies and non-profit organizations. Research into diagnosis and optimum treatment of the disease is progressing rapidly, with new advances reported every day. Colorectal Cancer presents reviews, analysis and commentary. on all aspects of colorectal cancer.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
